Steris | STE - Selling And Administration Expenses


Steris reported $369.7M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
3M USD 1.06B 317M Jun/2026
Accuray USD 124.78M 2.54M Dec/2025
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
CONMED USD 145.55M 3.85M Jun/2026
Cooper Companies USD 676.2M 303.1M Mar/2026
Dexcom USD 358.7M 9M Jun/2026
Ecolab USD 1.14B 39.2M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Fortive USD 417.9M 600K Jun/2026
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 286.82M 10.95M Jun/2026
Haemonetics USD 118.94M 1.99M Jun/2026
Idexx Laboratories USD 288.09M 11.76M Jun/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 166.22M 12.01M Jun/2026
Intuitive Surgical USD 617.9M 4.6M Jun/2026
J&J USD 6.42B 381M Jun/2026
Olympus JPY 125.03B 14.31B Jun/2026
Orthofix International USD 130.35M 11.31M Dec/2025
Owens Minor USD 258.98M 7.5M Dec/2025
ResMed USD 290.65M 10.86M Jun/2026
Steris USD 369.7M 17.9M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026